Barclays’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80
| Closed | -$1K | – | 4469 |
|
|
2025
Q1 | $1K | Hold |
80
| – | – | ﹤0.01% | 4323 |
|
|
2024
Q4 | $1K | Hold |
80
| – | – | ﹤0.01% | 4330 |
|
|
2024
Q3 | $1K | Sell |
80
-23
| -22% | -$288 | ﹤0.01% | 4276 |
|
|
2024
Q2 | $1K | Sell |
103
-3,435
| -97% | -$33.4K | ﹤0.01% | 4143 |
|
|
2024
Q1 | $55K | Sell |
3,538
-3,221
| -48% | -$50.1K | ﹤0.01% | 3802 |
|
|
2023
Q4 | $189K | Sell |
6,759
-16,301
| -71% | -$456K | ﹤0.01% | 3529 |
|
|
2023
Q3 | $1.1M | Buy |
23,060
+4,515
| +24% | +$215K | ﹤0.01% | 2028 |
|
|
2023
Q2 | $1.78M | Buy |
18,545
+13,042
| +237% | +$1.25M | ﹤0.01% | 1814 |
|
|
2023
Q1 | $624K | Sell |
5,503
-3,330
| -38% | -$378K | ﹤0.01% | 2492 |
|
|
2022
Q4 | $989K | Buy |
8,833
+954
| +12% | +$107K | ﹤0.01% | 2137 |
|
|
2022
Q3 | $1.01M | Buy |
7,879
+5,955
| +310% | +$765K | ﹤0.01% | 2119 |
|
|
2022
Q2 | $132K | Buy |
1,924
+992
| +106% | +$68.1K | ﹤0.01% | 3352 |
|
|
2022
Q1 | $132K | Sell |
932
-12,153
| -93% | -$1.72M | ﹤0.01% | 3547 |
|
|
2021
Q4 | $2.18M | Buy |
13,085
+10,688
| +446% | +$1.78M | ﹤0.01% | 1761 |
|
|
2021
Q3 | $334K | Buy |
2,397
+1,179
| +97% | +$164K | ﹤0.01% | 2767 |
|
|
2021
Q2 | $582K | Sell |
1,218
-1,533
| -56% | -$733K | ﹤0.01% | 2402 |
|
|
2021
Q1 | $1.13M | Buy |
2,751
+1,569
| +133% | +$646K | ﹤0.01% | 2227 |
|
|
2020
Q4 | $578K | Sell |
1,182
-339
| -22% | -$166K | ﹤0.01% | 2262 |
|
|
2020
Q3 | $862K | Buy |
1,521
+111
| +8% | +$62.9K | ﹤0.01% | 2012 |
|
|
2020
Q2 | $135K | Buy |
1,410
+804
| +133% | +$77K | ﹤0.01% | 3000 |
|
|
2020
Q1 | $43K | Sell |
606
-1,221
| -67% | -$86.6K | ﹤0.01% | 3160 |
|
|
2019
Q4 | $126K | Buy |
1,827
+840
| +85% | +$57.9K | ﹤0.01% | 3373 |
|
|
2019
Q3 | $79K | Buy |
987
+264
| +37% | +$21.1K | ﹤0.01% | 3511 |
|
|
2019
Q2 | $47K | Buy |
723
+409
| +130% | +$26.6K | ﹤0.01% | 3850 |
|
|
2019
Q1 | $43K | Buy |
314
+303
| +2,755% | +$41.5K | ﹤0.01% | 3708 |
|
|
2018
Q4 | $1K | Sell |
11
-382
| -97% | -$34.7K | ﹤0.01% | 4007 |
|
|
2018
Q3 | $60K | Buy |
393
+278
| +242% | +$42.4K | ﹤0.01% | 3675 |
|
|
2018
Q2 | $20K | Sell |
115
-264
| -70% | -$45.9K | ﹤0.01% | 3646 |
|
|
2018
Q1 | $56K | Sell |
379
-1,183
| -76% | -$175K | ﹤0.01% | 3463 |
|
|
2017
Q4 | $317K | Sell |
1,562
-570
| -27% | -$116K | ﹤0.01% | 2388 |
|
|
2017
Q3 | $684K | Buy |
2,132
+1,370
| +180% | +$440K | ﹤0.01% | 1768 |
|
|
2017
Q2 | $173K | Sell |
762
-985
| -56% | -$224K | ﹤0.01% | 2521 |
|
|
2017
Q1 | $393K | Buy |
1,747
+1,545
| +765% | +$348K | ﹤0.01% | 2102 |
|
|
2016
Q4 | $40K | Sell |
202
-183
| -48% | -$36.2K | ﹤0.01% | 2905 |
|
|
2016
Q3 | $94K | Buy |
385
+355
| +1,183% | +$86.7K | ﹤0.01% | 2457 |
|
|
2016
Q2 | $18K | Buy |
30
+20
| +200% | +$12K | ﹤0.01% | 2845 |
|
|
2016
Q1 | $5K | Sell |
10
-26
| -72% | -$13K | ﹤0.01% | 3066 |
|
|
2015
Q4 | $25K | Buy |
+36
| New | +$25K | ﹤0.01% | 2656 |
|